Radiopharm Theranostics L... (RADX)
NASDAQ: RADX
· Real-Time Price · USD
5.88
-0.07 (-1.18%)
At close: Sep 25, 2025, 3:58 PM
5.77
-1.87%
After-hours: Sep 25, 2025, 04:10 PM EDT
-1.18% (1D)
| Bid | 5.77 |
| Market Cap | 7.57M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -3.48 |
| PE Ratio (ttm) | -1.69 |
| Forward PE | -1.59 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 7.18 |
| Volume | 78,316 |
| Avg. Volume (20D) | 29,028 |
| Open | 5.95 |
| Previous Close | 5.95 |
| Day's Range | 5.62 - 6.90 |
| 52-Week Range | 3.50 - 50.82 |
| Beta | 0.90 |
| Ex-Dividend Date | n/a |
About RADX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RADX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RADX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+4.9%
Radiopharm Theranostics shares are trading higher ...
Unlock content with
Pro Subscription
3 months ago
+11.18%
Radiopharm Theranostics shares are trading higher after the company announced preclinical data from studies with the Lu177-B7H3-monoclonal antibody RV01.